Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Report 2026

Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview

• Ophthalmic Artificial Intelligence-Assisted Diagnosis market size has reached to $2.17 billion in 2025 • Expected to grow to $5.03 billion in 2030 at a compound annual growth rate (CAGR) of 18.2% • Growth Driver: Rising Eye Disorders Driving Demand For The Market Due To Increasing Digital Eye Strain And Vision Impairments • Market Trend: Advancements In AI-Driven Platforms Transforming Ophthalmic Diagnostics And Patient Care • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Ophthalmic Artificial Intelligence-Assisted Diagnosis Market?

Ophthalmic artificial intelligence-assisted diagnosis refers to the use of AI technologies to analyze eye-related medical data, such as retinal images or patient records, to detect, diagnose, or monitor eye diseases. It combines algorithms such as machine learning and deep learning with imaging and clinical data to support faster, more accurate, and automated decision-making in ophthalmology. The main types of ophthalmic artificial intelligence-assisted diagnosis are cloud-based and on-premises. Cloud-based refers to AI systems hosted on remote servers and accessed via the internet. The technologies involved include deep learning, machine learning, natural language processing (NLP), computer vision, and others, and are applied in settings such as hospitals, clinics, and imaging centers.

What Is The Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Growth Forecast?

The ophthalmic artificial intelligence-assisted diagnosis market size is expected to see rapid growth in the next few years. It will grow to $5.03 billion in 2030 at a compound annual growth rate (CAGR) of 18.2%. The growth in the forecast period can be attributed to growth of cloud-based ai diagnostic platforms, expansion of tele-ophthalmology services, improved ai algorithms for rare eye disorders, partnerships between ai developers and hospitals, increased adoption of predictive ophthalmology. Major trends in the forecast period include AI-based retinal imaging analysis, deep learning-powered disease detection, predictive ophthalmology models, automated patient record analysis, integration of ai with clinical workflows.

Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Segmentation

1) By Type: Cloud-Based, On-Premises 2) By Technology: Deep Learning, Machine Learning, Computer Vision, Other Technologies 3) By Application: Hospital, Clinic, Imaging Centre Subsegments: 1) By Cloud-Based: Public Cloud, Private Cloud, Hybrid Cloud 2) By On-Premises: Local Server Deployment, Enterprise Data Center Deployment, Private Network Deployment

What Is The Driver Of The Ophthalmic Artificial Intelligence-Assisted Diagnosis Market?

The rising prevalence of eye disorders is expected to propel the growth of the ophthalmic artificial intelligence-assisted diagnosis market going forward. Eye disorders refer to medical conditions or abnormalities that affect the structure or function of the eye, potentially impairing vision or eye health. Eye disorders are rising due to increasing screen time from digital device usage, which causes digital eye strain, dryness, and long-term vision issues from prolonged blue light exposure and reduced blinking rates. Ophthalmic artificial intelligence-assisted diagnosis helps by analyzing medical images and patient data to detect, classify, and predict eye disorders early and accurately, enabling timely treatment and reducing the risk of vision loss. For instance, in August 2023, according to the World Health Organization (WHO), a Switzerland-based United Nations agency, estimates from 2023 show that more than 2.2 billion people live with near or distance vision impairment—over 1 billion of which are preventable or untreated—while refractive errors and cataracts remain the leading causes, and access to effective interventions reaches only 36% of those affected by refractive error–related impairment and just 17% of those with cataract-related impairment. Therefore, the rising prevalence of eye disorders is driving the growth of the ophthalmic artificial intelligence-assisted diagnosis industry.

Key Players In The Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

Major companies operating in the ophthalmic artificial intelligence-assisted diagnosis market are IDx Technologies Inc., Digital Diagnostics Inc., AEYE Health Inc., Eyenuk Inc., OphtAI, Oivi Tech Private Limited, Altris Inc., JuneBrain Inc., Mediwhale Inc., MONA.health BV, Remidio Innovative Solutions Pvt. Ltd., Retinalyze System A/S, Retmarker, RetinaRisk, Ikerian AG, VoxelCloud Inc., Visulytix Ltd., Aiforia Technologies Plc, DeepTek Inc., EyRIS Pte Ltd., Neurodynamics Solutions Inc.

Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Trends and Insights

Major companies operating in the ophthalmic artificial intelligence-assisted diagnosis market are focusing on developing innovative solutions, such as an ocular data-as-a-service platform, to enhance diagnostic accuracy, streamline patient care, and enable predictive insights for eye disorders. An ocular data-as-a-service platform refers to a digital solution that delivers eye health data on demand, enabling ophthalmologists, clinics, and AI diagnostic tools to access, share, and analyze retinal images and other ocular information remotely for improved diagnosis, monitoring, and research. For instance, in May 2025, Topcon Healthcare Solutions Inc., a US-based digital healthcare solutions company, launched IDHea, designed to streamline ophthalmic diagnostics and improve patient outcomes. It’s a cloud-based platform that accelerates AI and digital health innovation by providing fast, secure access to real-world and clinical ocular datasets. It empowers researchers to drive breakthroughs in both eye and systemic disease care by transforming clinical data into actionable, AI-powered insights. Built on the FAST principle, Fast, Accessible, Safe, and Transparent, IDHea enables predictive, personalized, and proactive patient care while upholding rigorous privacy and governance standards.

What Are Latest Mergers And Acquisitions In The Ophthalmic Artificial Intelligence-Assisted Diagnosis Market?

In May 2025, Topcon Healthcare Inc., a US-based digital healthcare solutions company, acquired RetInSight GmbH for an undisclosed amount. With this acquisition, Topcon Healthcare aims to accelerate its vision of healthcare from the eye by enhancing access to intelligent diagnostics that improve high-quality eye care, reduce healthcare costs, and improve clinical outcomes globally through AI-powered retinal imaging innovation. RetInSight GmbH is an Austria-based medtech company that offers ophthalmic artificial intelligence-assisted diagnosis.

Regional Outlook

North America was the largest region in the ophthalmic artificial intelligence-assisted diagnosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Ophthalmic Artificial Intelligence-Assisted Diagnosis Market?

The ophthalmic artificial intelligence-assisted diagnosis market includes revenues earned by entities by providing services such as technical support and maintenance, clinical trial support, training and consultation, data management, and annotation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The ophthalmic artificial intelligence-assisted diagnosis market also includes sales of wearable eye-tracking devices, retinal scanners, AI-enabled slit-lamp imaging devices, and portable artificial intelligence ophthalmic diagnostic kits. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.